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Essentially all of the MTBE produced or
imported in the United States is used in the
oxygenation of gasoline. Gasoline can con-
tain up to 15% MTBE byvolume.
In light of the concerns raised over the
use of MTBE, many wonder why the oxy-
genated fuel program was implemented
without further research being conducted
first. "Congress required the use of oxy-
genates in the Clean Air Act," says Hitzig.
"The EPA is simply following the statute
that was passed. There was a lot known
about the risks of MTBE at the time, but
maybe the people working on the legislation
didn't know [that]."
"A program should be evaluated for
[MTBE's] effectiveness as well as its health
effects before it is put into use," says Melnick.
"There are obviously serious questions about
MTBE's effectiveness and its role as an envi-
ronmental contaminant. So the question is,
arewe gainingsufficient benefits to make this
program worthwhile." Much more research
will be needed before this question may be
answeredwith anycertainty.
Telomerase Gene Identified
One more step toward understanding the
uncontrolled proliferation of immortal can-
cer cells was taken in August as two separate
groups identified the putative human telom-
erase gene for the first time. These results
were published almost simultaneously in the
scientificjournals Scienceand Cell.
The gene produces the enzyme necessary
to maintain telomeres, the structures at the
end ofeach chromosome. When cells divide
theylose, through the normal process ofpro-
liferation, a few ofthe special base pairs that
make up the telomeres. For most cells, this is
presumably part ofthe natural aging process
of the cell. When these base pairs run out,
the cell can no longer divide properly.
However, for several specialized normal
cells in the body it is imperative to be able
to continue to divide past the limits nor-
mally enforced by the length of the telom-
eres. Two examples include gamete cells,
which carry genetic material from one gen-
eration to the next, and the cells in a devel-
oping embryo. In the delicate mechanics of
the cell, the enzyme telomerase is turned on
and off as it is needed to maintain the
length ofthe telomeres.
In contrast to specialized cells, normal
cells do not express telomerase. In almost all
tumor cells, however, telomerase is
expressed. When telomerase is turned on
inappropriately, the cell can then become
immortal, meaning it can continue to divide
indefinitely. The discovery of the gene-
encoding part ofthe telomerase enzyme will
allow scientists to probe deeper into the
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Cancer Bytes
All cancers, scientists have learned in the last 20 years, begin with a malfunction in the
genetic machinery ofa cell, causing it to duplicate itselfwithout restraint. Such knowl-
edge brings with it not only new hope for stopping these deadly diseases, but also a great
challenge for scientists-to discern the location and function ofthe culprit genes among
the over 100,000 in each human cell.
Now, a powerful new tool on theWorld Wide Web is making this task much more
feasible. The Cancer GenomeAnatomy Project (CGAP), which was launched inAugust
1997, provides scientists with data on the genes expressed in cancerous, precancerous,
and normal cells from several different tissues and organs. The site, located at
http://www.ncbi.nlm.nih.gov/ncicgap/, was developed
by the National Cancer Institute and the National
Library ofMedicine. Information accumulated there will
allow scientists to determine how gene expression
changes as cells become cancerous, and use this knowl-
edge to direct their research toward suspect genes or
their protein products.
Such research could lead to newways to stop malig-
nant tumors, but even iffulfillment ofthat goal remains
elusive, the genetic "fingerprints" in the CGAP gene
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index will serve other valuable functions. Using this information, doctors will be able to
determine ifcells are cancerous before a tumor forms by looking at what genes are being
expressed in them. This will allow treatment regimens to be started earlier, quite possi-
bly saving the lives ofmany patients. Doctors could also use this information to better
match treatments to patients by using genetics to distinguish cancers that look nearly
identical but respond differently to treatments.
Another goal ofthe CGAP is to promote the development ofnew technologies that
will add to the breadth of information available on the site. Current technology, for
example, makes it difficult to sequence the full lengths ofthe genes expressed in a cell,
so much ofthe CGAP database is made up ofexpressed sequence tags short sequences
from randomly isolated portions ofgenes that can be used to identity genes but that do
not necessarily contain all oftheir genetic information. To address this shortcoming, the
CGAP has made $2.5 million in grants available to researchers to develop methods to
efficiently map the full-length sequences ofall the genes expressed in cells. Other CGAP
grants support the development oftechnologies to scan the genomes ofcancer cells and
to evaluate molecular changes in tumor specimens.
From the CGAP home page, information on CGAP grants can be found by fol-
lowing the Information link on the left menu bar. Also on this menu bar is a link to a
description of one ofthe newest technologies being used to gather data for the CGAP
web site: clicking on the picture ofthe laser capture microdissection microscope brings
users to an account ofhow this tool allows scientists to isolate only a few cells ofinterest
from a tissue sample forgenetic analysis, rather than using larger specimens that may
contain several types ofcels.
Ryrent for the View LihrariPe link. al other links on the home naze take users to
other sites or to information on the methods used to create the
CGAP database. By following the View Libraries link, users are
led to the heart ofthe site, alist ofthe tissue libraries for which
CGAP genetic data are available. Choosing a link in this list will
lead to the genetic library page for that tissue. Each library page
includes information about t e tissue donor, a link to down oad
all of the expressed sequence tags observed in that library, and
brief descriptions of the genes found in the library that seem
particularly interesting (either because they code for a large por-
tion ofthe proteins found in the cell or because they are unique
to that library or tissue).
Each gene of interest on the library page is a link to another page of additional data
about that gene and the protein for whic it codes. The gene pages contain links to
maps that show the location ofthe gene on the human chromosomes, information on
other libraries in which the gene is expressed, and links to the DNA sequence that com-
poses that gene.
In many cases, the information on the CGAP site is incomplete-evidence ofthe
enormous amount ofwork that has yet to be done. But using the Internet to coordinate
the effort increases the likelihood that the CGAP will obtain its goal ofachieving a com-
prehensive molecular characterization of the broad spectrum of normal, precancerous,
and malignant cells.
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mystery of how the correct and incorrect
expression of telomerase is linked to the
development ofcancer.
The first group to describe the gene was
headed by Toru Nakamura and included
Nobel Prize winner Thomas Cech of
Colorado University at Boulder and the
Howard Hughes Medical Institute, as well
as six additional authors, five of whom
work for Geron Corporation of Menlo
Park, California. Their findings were pub-
lished in the 15 August 1997 issue of
Science. "We hope the cloning of this gene
will lead to the discovery and use of new
drugs in the fight against cancer," said Greg
Morin ofGeron, one ofthe coauthors.
In the 22 August 1997 issue of Cell a
second group, led by Matthew Meyerson of
the Massachusetts Institute of Technology
(MIT), announced their discovery of the
same gene. The group also included Robert
Weinberg of the Whitehead Institute of
biomedical Kesearch
at MIT and eleven
others.
Jerry Shay, a pro-
fessor of cell biology
and neurosciences at
University of Texas
Southwestern Medical
Center in Dallas and a
recognized leader in
telomerase research,
said of the simultane-
ous cloning of this
gene, "This is impor-
tant because we can
now begin to under-
stand how telomerase
works. Ifwe can't find
a cure for cancer, we
need to start detecting
it earlier so we can
stop it-or control
it-before it spreads.
Telomerase can be
used as an early defini-
tive marker ofcancer."
Also newsworthy
is the way in which
the telomerase gene
was cloned. "It should
have taken a couple of
years to clone," said
Shay, "but because the
Human Genome
Project clones ESTs
[expressed sequence
tags] the groups were
able to pick it out
through its homology to the yeast telom-
erase gene." An EST is a 400- or 500-base-
pair fragment that is identified through
random sequencing ofcDNA libraries. The
groups were able to look at these ESTs and
identify those that showed homology, or
identical sequence, with the already identi-
fied yeast telomerase gene. Therefore, the
work ofthe Human Genome Project accel-
erated by years the cloning and identifica-
tion ofan unknown gene.
"This is all early, basic, science-type
stuff. We are a long way from being able to
extend life and cure cancer," said Shay.
"But these are profound things to even be
contemplating."
A New Reason Not to Smoke
New evidence provides support for the
argument that smoking may cause cervical
cancer, not just in smokers but also in non-
smoking women who are exposed to envi-
ronmental cigarette smoke. The study,
reported in the 18 June 1997 issue of the
A question of cancer. New evidence shows
that environmental tobacco smoke may have
serious health effects for women including a
strong linkto cervical cancer.
Journal of the National
Cancer Institute, is the
first to find a tobacco-
specific carcinogen in
samples of cervical
mucus taken from both
smoking and nonsmok-
ing women. The car-
cinogen is 4-(methyl-
nitrosamino) 1 -l(3-
pyridyl)-1-butanone
(NNK), an N-nitro-
samine that is formed
during the processing
and burning of tobacco
products. NNK is one
of the most potent
carcinogens found in
tobacco smoke. It has
been detected in the
sidestream smoke ofcig-
arettes (the smoke that
wafts from a smoldering
cigarette), which means
that not only smokers
but also nonsmokers
who breathe in sec-
ondary cigarette smoke
are exposed to NNK.
The study was con-
ducted by Bogdan
Prokopczyk, head of the
section of bio-organic
chemistry in the division
of cancer etiology and
prevention at theAmerican
Health Foundation in
Valhalla, New York, and
Steven E. Waggoner, an assistant professor
of gynecologic oncology at the University
ofChicago Medical Center, and colleagues.
The study cohort consisted of 25 women,
15 ofwhom smoked and 10 ofwhom did
not smoke. The women were aged 18-45,
were free ofany active genital tract disease,
and were not currently using oral contra-
ceptives. The scientists collected cervical
mucus samples from the women and used
highly sensitive gas chromatography-mass
spectrometry analyses to identify and quan-
tify the NNK in the samples. Of 26 sam-
ples taken (one woman gave two samples),
only one-taken from one of the non-
smoking women-did not contain some
measurable amount of NNK. Among the
other 9 nonsmokers, NNK concentrations
ranged from 4.1 to 30.8 nanograms per
gram (ng/g) of mucus, approximately one-
third lower than the amounts found in the
samples taken from the smokers, which
ranged from 11.9 to 115.0 ng/g.
Scientists have known for some time
that there is a link between cigarette smoke
and cervical cancer, but the precise nature
of the link is still uncertain. Prior research
has determined that noncarcinogenic com-
pounds from cigarette smoke, such as nico-
tine and its metabolite cotinine, can be
detected in the cervical mucus. There is
also evidence that cigarette smoke is capa-
ble of causing damage to DNA in cervical
epithelial tissue. But the new findings are
the first time that a carcinogen specific to
tobacco has been found in the cervical
mucus of women who smoke. The link
between smoking and cervical cancer has
been greatly strengthened by these latest
findings, which, according to the report's
authors, lend "biologic plausibility in sup-
port of the association between cigarette
smoking and [cervical cancer]."
In the United States in 1996, there
were an estimated 15,700 new cases ofcer-
vical cancer and 4,900 deaths from the dis-
ease. According the JNCI study, cervical
cancer is the top cause ofdeath from cancer
in women in developing countries, and is
one of the most common cancers among
U.S. women aged 15-54. The foremost
risk factor for cervical cancer is infection
with certain strains of the human papillo-
mavirus (HPV). The DNA-level effects of
such viruses are found in up to 93% ofall
examined cervical tumors, but these effects
alone are not thought to be enough to
induce carcinogenesis. Many other factors
are associated with cervical cancer, includ-
ing deficiencies in micronutrients such as
beta carotene and folate, impaired immune
status, early onset of sexual activity, and
cigarette smoking.
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